A meta-analysis finds mixed evidence, not proof cannabis changes oral cancer…

Association of Cannabis Use and Risks of Oral Cancer: A Systematic Review and Meta-Analysis.

Health science reports • • Review • Highly Relevant
🤖

AI Summary

This systematic review and meta-analysis examined whether cannabis use is associated with oral cancer risk in adults, combining 11 observational studies with 245,594 participants. Across the studies, the pooled result suggested lower odds of oral cancer among people reporting cannabis use. However, this association was seen in case-control studies and was not supported by the cohort study, which found no statistically significant association.

The findings do not establish that cannabis prevents oral cancer or that it is an independent risk factor. The studies varied substantially, and residual confounding may have affected the results. The authors call for prospective research to clarify the relationship. This is an abstract-based summary; the abstract does not provide enough detail to assess individual study methods or fully resolve the conflicting findings.

💡 Key Findings

1
Across 11 observational studies involving 245,594 participants, the pooled analysis suggested lower odds of oral cancer associated with cannabis use.
High
80%
2
The inverse association appeared in case-control studies, while the cohort study found no statistically significant association.
High
80%
3
The evidence does not establish cannabis as an independent oral cancer risk factor; substantial heterogeneity and potential residual confounding limit interpretation.
High
90%

📄 Original Abstract

BACKGROUND: Oral cancer is a major health concern globally, with its etiology linked to factors such as tobacco use, alcohol consumption, and HPV infection. With changing lifestyle behaviors and the increased legalization of cannabis, its potential role in oral carcinogenesis has garnered attention. This systematic review and meta-analysis aims to evaluate the association between cannabis use and the risk of developing oral cancer. METHODS: A systematic search was conducted across PubMed, EMBASE, and Web of Science to identify studies up to August 15, 2025. Inclusion criteria encompassed adult participants and observational studies on cannabis use and oral cancer risk. Meta-analysis utilized random-effects models to compute pooled odds ratios (ORs) in R software version 4.4. Newcastle Ottawa scale was used for quality assessment. RESULTS: From 1,063 records, 11 studies met the inclusion criteria with a total sample size of 245,594 participants. The meta-analysis revealed a pooled OR of 0.481 (95% CI: 0.306 to 0.757), suggesting a potential reduced risk of oral cancer with cannabis use, particularly noted in case-control studies (pooled OR: 0.455, 95% CI: 0.291 to 0.713). However, cohort study showed no significant association (pooled OR: 2.51, 95% CI: 0.244 to 25.823), and high heterogeneity was observed across studies. CONCLUSION: Current evidence does not support cannabis use as an independent risk factor for oral cancer. Although some case-control studies suggested an inverse association, this finding was not supported by cohort studies and should be interpreted cautiously given the substantial heterogeneity and potential for residual confounding. Further prospective studies are needed to clarify this relationship.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.